Novel CIC variants identified in individuals with neurodevelopmental phenotypes

Authors:
  • ALAnna Lehman
    Anna Lehman
  • TSthe CAUSES Study
    the CAUSES Study

Abstract
Heterozygous pathogenic variants in CIC, which encodes a transcriptional repressor, have been identified in individuals with neurodevelopmental phenotypes. To date, 11 CIC variants have been associated with the CIC-related neurodevelopmental syndrome. Here, we describe three novel and one previously reported CIC variants in four individuals with neurodevelopmental delay. Notably, we report for the first time a de novo frameshift variant specific to the long isoform of CIC (CIC-L, NM_001304815.1:c.1100dup, p.Pro368AlafsTer16) in an individual with speech delay, intellectual disability and autism spectrum disorder. Our investigation into the function of CIC-L reveals that partial loss of CIC-L leads transcriptional de-repression of CIC target genes. We also describe a missense variant (NM_015125.3:c.683G>A, p.Arg228Gln) in an individual with a history of speech delay and relapsed pre-B acute lymphoblastic leukemia (ALL). Functional studies of this variant suggest a partial loss of CIC transcriptional repressor activity. Our study expands the list of CIC pathogenic variants and contributes to the accumulating evidence that CIC haploinsufficiency or partial loss of function is a pathogenic mechanism causing neurodevelopmental phenotypes.
Funding Information
  • Genome British Columbia
  • Natural Sciences and Engineering Research Council of Canada (RGPIN‐2019‐06153)
  • Canadian Institutes of Health Research (PJT‐178103)
  • Canada Foundation for Innovation (38985)
  • Canada Research Chairs
  • Institute of Human Development, Child and Youth Health (MRC‐177440)

This publication has 19 references indexed in Scilit: